Citation Impact
Citing Papers
Pathogenicity Islands in BacterialPathogenesis
2004
Expanded therapeutic potential in activity space of next-generation 5-nitroimidazole antimicrobials with broad structural diversity
2013 StandoutNobel
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
Click chemistry-facilitated comprehensive identification of proteins adducted by antimicrobial 5-nitroimidazoles for discovery of alternative drug targets against giardiasis
2020 StandoutNobel
AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms
2017
Escaping Death: Mitochondrial Redox Homeostasis in Cancer Cells
2017
Emerging roles of PKM2 in cell metabolism and cancer progression
2012 StandoutNobel
Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression
2017 Standout
Advances and challenges in targeting FGFR signalling in cancer
2017
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
2012 Standout
Metronidazole Is Still the Drug of Choice for Treatment of Anaerobic Infections
2010
The gut microbiota, bacterial metabolites and colorectal cancer
2014 Standout
TGF-β: the master regulator of fibrosis
2016 Standout
National Survey on the Susceptibility ofBacteroides fragilisGroup: Report and Analysis of Trends for 1997–2000
2002
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
2013 StandoutNobel
Genetic analysis of mechanisms of multidrug resistance in a clinical isolate of Bacteroides fragilis
2006
Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate
2010
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010–2011
2014
Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe
2003
Extracellular Matrix Degradation and Remodeling in Development and Disease
2011 Standout
Antibiotics and anaerobes of gut origin
2003
Prevalence of Antibiotic Resistance in Anaerobic Bacteria: Worrisome Developments
2004
Association between the Presence of Enterococcal Virulence Factors Gelatinase, Hemolysin, and Enterococcal Surface Protein and Mortality among Patients with Bacteremia Due toEnterococcus faecalis
2002
Enterotoxigenic Bacteroides fragilis: A potential instigator of colitis
2007
Inflammation and Colon Cancer
2010 Standout
Diabetic nephropathy—emerging epigenetic mechanisms
2014
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Acute kidney injury
2019 Standout
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Inflammasomes in carcinogenesis and anticancer immune responses
2012
Pyroptosis: mechanisms and diseases
2021 Standout
Characterization of the Bacteroides fragilis pathogenicity island in human blood culture isolates
2005
Acute kidney injury
2021 Standout
Emergence of fluoroquinolone resistance among Bacteroides species
2003
Effect of Solar Particle Event Radiation on Gastrointestinal Tract Bacterial Translocation and Immune Activation
2011 StandoutNobel
Chronic kidney disease
2017
Cell cycle arrest and the evolution of chronic kidney disease from acute kidney injury
2014
Progression after AKI
2015
The toxins of Bacteroides fragilis
2001
Oxidative Stress in Cancer
2020 Standout
Influence of diet on the gut microbiome and implications for human health
2017 Standout
Has Antifungal Susceptibility Testing Come of Age?
2002
Anaerobes: Antibiotic resistance, clinical significance, and the role of susceptibility testing
2005
Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders
2013 Standout
Dysregulated pH: a perfect storm for cancer progression
2011 Standout
Antimicrobial Resistance and Susceptibility Testing of Anaerobic Bacteria
2014
Recent developments in epigenetics of acute and chronic kidney diseases
2015
Discovering protein−ligand chalcogen bonding in the protein data bank using endocyclic sulfur-containing heterocycles as ligand search subsets
2017
Cancer-related inflammation and treatment effectiveness
2014 Standout
Regulation of Metabolism by Hypoxia-Inducible Factor 1
2011 StandoutNobel
Catalytic CC, CN, and CO Ullmann‐Type Coupling Reactions
2009 Standout
Mitochondria and cancer
2012 Standout
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
2011 StandoutNobel
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
2020 Standout
Chronic Kidney Disease
2016 Standout
Current Concepts in Laboratory Testing to Guide Antimicrobial Therapy
2012
Reemergence of Anaerobic Bacteremia
2007
In vitro activity of tigecycline against Bacteroides species
2005
Mitochondrial Morphofunction in Mammalian Cells
2018
Multicenter Study of In Vitro Susceptibility of the Bacteroides fragilis Group, 1995 to 1996, with Comparison of Resistance Trends from 1990 to 1996
1999
National Survey on the Susceptibility of Bacteroides fragilis Group: Report and Analysis of Trends in the United States from 1997 to 2004
2007
Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
2011 Standout
Actinomyces and Related Organisms in Human Infections
2015 Standout
Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Sources: Potential Public Health Implications
2018 Standout
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
2015 StandoutNobel
Fibroblast Growth Factor Receptor Inhibitors as a Cancer Treatment: From a Biologic Rationale to Medical Perspectives
2013
Isolation of Metronidazole-Resistant Bacteroides fragilis Carrying the nimA Nitroreductase Gene from a Patient in Washington State
2004
Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells
2011 StandoutNobel
Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Protects Against Acute Kidney Injury–Mediated Chronic Kidney Disease
2017
Click Chemistry-Facilitated Structural Diversification of Nitrothiazoles, Nitrofurans, and Nitropyrroles Enhances Antimicrobial Activity against Giardia lamblia
2017 StandoutNobel
EnterotoxigenicBacteroides fragilis: a Rogue among Symbiotes
2009
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
Combination therapy in combating cancer
2017 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth
2009
Cancer Genome Landscapes
2013 StandoutScience
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
2018 Standout
Azithromycin Inhibits the Formation of Flagellar Filaments without Suppressing Flagellin Synthesis in Salmonella enterica Serovar Typhimurium
2005 StandoutNobel
Guidelines for Treatment of Candidiasis
2004 Standout
Mechanisms of Renal Fibrosis
2017 Standout
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
2014 Standout
Chalcogen Bonding: An Overview
2018 Standout
Bacteroides: the Good, the Bad, and the Nitty-Gritty
2007 Standout
FGF4 induces epithelial-mesenchymal transition by inducing store-operated calcium entry in lung adenocarcinoma
2016
Guidelines for the Selection of Anti-infective Agents for Complicated Intra-abdominal Infections
2003
In Vitro Susceptibilities of the Bacteroides fragilis Group Species: Change in Isolation Rates Significantly Affects Overall Susceptibility Data
2002
Dynamin-related protein 1 mediates low glucose-induced endothelial dysfunction in human arterioles
2016
Community-acquired anaerobic bacteremia in adults: one-year experience in a medical center.
2005
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Optimization of the Conditions for Copper‐Mediated N‐Arylation of Heteroarylamines
2007
Works of Lee McDermott being referenced
Histone Deacetylase Inhibitor Enhances Recovery after AKI
2013
Antimicrobial Resistance and Clinical Outcome of Bacteroides Bacteremia: Findings of a Multicenter Prospective Observational Trial
2000
Screening and In Vitro Testing of Antifolate Inhibitors of Human Cytosolic Serine Hydroxymethyltransferase
2015
Fibroblast Growth Factor (FGF) and FGF Receptor-Mediated Autocrine Signaling in Non-Small-Cell Lung Cancer Cells
2008
RO4383596, an orally active KDR, FGFR, and PDGFR inhibitor: Synthesis and biological evaluation
2005
Design and evaluation of novel glutaminase inhibitors
2016
Novel combination of mitochondrial division inhibitor 1 (mdivi-1) and platinum agents produces synergistic pro-apoptotic effect in drug resistant tumor cells
2014
A PTBA small molecule enhances recovery and reduces postinjury fibrosis after aristolochic acid-induced kidney injury
2013